Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000676509 | SCV000617975 | likely benign | not provided | 2021-03-10 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25638290) |
Labcorp Genetics |
RCV000676509 | SCV001012958 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000676509 | SCV002544424 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | DNA2: BS2 |
Breakthrough Genomics, |
RCV000676509 | SCV005228120 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676509 | SCV000802293 | uncertain significance | not provided | 2017-10-12 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003915466 | SCV004733267 | benign | DNA2-related disorder | 2019-05-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |